A New York federal court has dismissed the majority of claims in a putative class action alleging that Revlon Age Defying with DNA Advantage® foundation and concealer were falsely advertised under state law. Elkind v. Revlon Consumer Prods. Corp., No. 14-2484 (E.D.N.Y., order entered May 14, 2015). The plaintiffs alleged that the marketing for the DNA Advantage® line of products misleads consumers with claims that they slow the aging process by affecting skin and DNA on a molecular or cellular level. The court rejected the claims lodged against the powder product for lack of standing, refused to grant an injunction and dismissed the women’s mislabeling claims as preempted by the federal Food, Drug, and Cosmetic Act. The plaintiffs’ deceptive advertising claims against the DNA Advantage® line’s foundation and concealer products will continue. Details on the May 2014 complaint appear in Issue 24 of this Report.